NIDA

Therefore, this Stress and COVID-19 (S&C) Study is designed to understand how COVID-19 is affecting substance use (SU) and mental health (MH) across different racial/ethnic communities.

This study enrolls pregnant and postpartum women into a multi-wave study to assess medical, economic, psychosocial and substance use risk across pregnancy and the perinatal period, studying associations of these factors to infant neurobehavioral development during the first year of life.

This project will build on an existing national pregnancy cohort study of women with a wide range of underlying health conditions to address COVID-19 symptoms, testing and antibody status, as well as the behaviors of participants during the pandemic.

This project will enhance the ACHESS smartphone app with new COVID-19 related features and then examine how patients use ACHESS features, how organizations refer patients to the ACHESS, how they interact with patients in ACHESS, and the overall impact of the ACHESS features.

The goal of this study is to leverage large comprehensive claims and electronic health data, capturing nearly half of the U.S. population from before the pandemic through 2026, to test our hypothesis that social and economic vulnerabilities, as well as economic side effects of the pandemic will escalate the prevalence of OUD and related harms.

The overarching objective of this project is to rigorously assess how state-level COVID-19 mitigation policies have affected psychological health and related mortality from drug overdose and suicide among working age and older adults.

This project aims to understand the broad impact of COVID-19 and related stressors on substance use and access to addiction treatment among Indigenous young adults living on or near reservations/reserves.

This project aims to characterize neurodevelopmental profiles in infants born to mothers with and without antenatal Covid-19 infection and examine the concurrent impact of social, economic, and substance use factors.

This project uses a randomized controlled trial of a novel mobile peer support app platform among a national sample of 1300 patients in recovery from opioid use disorders (OUDs), as an adjunct to usual care, during COVID-19.

Using existing healthcare data, this study seeks to quantify the effects of healthcare system responses to COVID-19 on outcomes among pregnant and postpartum women with OUD and describe how COVID-19 infection influences morbidity among pregnant women with OUD.